Irregular Periods Tied to 62% Higher Heart Disease Risk Over 26 Years

Menstrual cycle irregularities have long been linked to cardiovascular risk, but researchers have rarely distinguished between different underlying causes. This study breaks new ground by isolating functional hypothalamic amenorrhea (FHA) — absent or irregular cycles driven by low body mass index or high physical activity, without polycystic ovary syndrome traits — and examining whether it carries a unique cardiovascular disease (CVD) risk profile.

Using data from the Nurses' Health Study II, researchers followed 52,655 premenopausal women free of CVD from 1993 to 2019 — up to 26 years. FHA phenotype was defined by menstrual irregularity or absence combined with low BMI and/or high physical activity, explicitly excluding PCOS. Incident CVD (coronary heart disease and stroke), type 2 diabetes, hypertension, and elevated cholesterol were tracked as outcomes.

Over the follow-up period, 1,007 CVD events occurred. Women with FHA phenotype in mid-adulthood had a 62% higher risk of CVD overall, driven primarily by an 88% to nearly two-fold higher risk of coronary heart disease. FHA was also independently associated with type 2 diabetes risk (HR 1.86). In contrast, women with non-FHA menstrual irregularity showed elevated risk of cholesterol, hypertension, and diabetes, but not CVD, underscoring that the etiology of cycle disruption meaningfully shapes long-term risk. Notably, FHA in early adulthood was not associated with adverse outcomes, suggesting mid-adulthood is the critical window.

For clinicians, these findings reframe the cardiovascular significance of low-BMI-driven or exercise-driven amenorrhea — a pattern often seen in athletes and highly active women. Rather than viewing FHA as benign, physicians should consider it an early cardiometabolic warning sign. Menstrual history deserves a place alongside standard CVD risk screening tools.

Caveats include reliance on the abstract only, potential residual confounding, and the cohort's predominantly nurse population, which may limit generalizability.